Patent Assignment
Reel/Frame 013250/0043
Assignment of Assignor's Interest
Recorded: 2002-09-03
Pages: 3
Assignor
HORN, GERALD
Executed: 2002-03-08
Assignee
HMT PHARMA, INC.
2436 SOUTH 6TH AVENUE, NORTH RIVERSIDE, ILLINOIS, 60546
Covered Properties
(6)
Method for optimizing pupil size using alpha antagonist
Patent:
6,291,498 →
Application:
09/662,945 →
Night Vision Composition
Patent:
6,730,065 →
Application:
09/675,988 →
Method and composition which reduces stimulation of muscles which dilate the eye
Application:
09/705,526 →
Ophthalmic Formulation Which Modulates Dilation
Patent:
6,420,407 →
Application:
09/710,758 →
Ophthalmic formulations comprising an imidazoline
Application:
09/854,414 →
Publication:
US 2002/0082288
Ophthalmic Formulation Which Modulates Dilation
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Mar 25, 2003
From: HORN, GERALD
To: OCULARIS PHARMA, INC.
Reel/Frame 013894/0887 →
Assignment of Assignor's Interest
Nov 19, 2018
From: OCULARIS PHARMA, INC.
To: OCULARIS PHARMA, LLC
Reel/Frame 047539/0082 →
Merger
Nov 20, 2018
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 047555/0568 →